A review article containing contested claims about the tropical medicine drug as a COVID-19 treatment was listed as “provisionally accepted” on the journal’s website before being removed this week.

A response to Ada Hagan’s opinion piece suggesting that our study “compromises response to gender bias.”

A recent analysis that claimed no evidence of gender-based peer review outcomes fails to account for several factors.

An analysis of data from nearly 150 journals across scientific disciplines finds that, if anything, manuscripts authored by women are treated more favorably than those submitted by men.

The study, published in a peer-reviewed journal, has attracted widespread derision from researchers.

While some academics have called for compensation for assessing other scientists’ work, publishers haven’t warmed to the idea.

The changes, which affect the declarations authors have to sign and the peer-review process, have received a mixed response from the scientific community.

The open access publication will use AI to identify the most pressing manuscripts in need of peer review.

Preprints from the first round of seroprevalence studies indicate that many more people have been infected with the virus than previously reported. Some of these studies also have serious design flaws.